ANDA 80857, held by Chartwell Molecular. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 80857 (Diphenylan Sodium), held by Chartwell Molecular, was first approved by FDA on Dec 3, 1976, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 3, 1976 | Original application | Approved | None posted |
| Diphenylan Sodium30MG PROMPT · capsule;oral | Phenytoin Sodium | Discontinued |
| Diphenylan Sodium100MG PROMPT · capsule;oral | Phenytoin Sodium | Discontinued |
| Sep 9, 1985 | Supplement 14Manufacturing | Approved | None posted |
| Dec 3, 1976 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters